Investing in Early Stage Technology
Kevin Sheehy, health tech strategy consultant at Genulin Consulting Limited, invites you to a roundtable meeting where industry experts will share their knowledge of the local investment opportunities.
Date: Thursday 21 September Time: 13h00 to 17h30
Venue: ChristchurchNZ (New Premises); BNZ Centre; Level 3; 101 Cashel Street
The New Zealand Health Technology Review 2016 identified capital raising as one of the top three challenges facing local companies. Many local companies are seeking early stage capital and cornerstone investors familiar with their challenges. Investing in local health technology offers
excellent potential for access to major international markets for those that can successfully grapple with the sector’s risks.
The roundtable aims to increase investor confidence in assessing early stage health tech opportunities and how to structure companies for success.
We have a fantastic group of speakers (Bios below) who will share their views and case studies on:
• The global health landscape – where are the pain points;
• Why NZ health tech is a great opportunity;
• What success looks like in health IT, medical devices and biotech;
• Partnering through seed and VC stages in the health tech sector.
1pm: – Kevin Sheehy – Director Genulin Consulting Limited
Introduction – Health system opportunities and challenges
1:30pm – William Lee – Commercial Director, Canterbury university Research and Innovation
Investment in NZ Health start-ups: how to partner with Universities
2pm – Duncan Mackintosh – Medical Research Commercialisation Fund – Brandon Capital
Overview of the MRCF funds and collaboration, with lessons learned.
2:30pm – Dr Phil Kearney – Director External Licensing, Merck Sharp & Dohme Australia|
What opportunities are on the MSD horizon
3pm – Kimberlee Jordan – National Technology Network Manager for Biotechnology, Callaghan Innovation
The opportunity in biotech and some NZ successes
3:30pm – Break for tea
4pm – Investment Manager Powerhouse ventures
What is different about health tech for an investor
4:30pm – Paul Morrison – Managing Director Ossis
Taking a medical device to the US, the capital needs
5pm – Roundtable discussion co-chaired by Duncan Mackintosh and local Angel Investor
What investors face in health tech.
5:30pm – Networking drinks
The aim of the meeting is to help the local investor community better grapple with the opportunity in health tech. We hope to be able to build investor confidence through knowledge of how to approach investing in health technology in New Zealand.
We have some great local and Australian speakers and should have a good cross section of people around the table for robust discussion on the day.
RSVPs and queries should be directed to firstname.lastname@example.org
As numbers are limited to 20 attendees, we’ll be allocating places to those who RSVP first.